India Emerging as Major Market for Biosimilar Immunotherapy, But Patient Awareness Still Lags: Oncologists
New Delhi: For many cancer patients in India, advanced treatments such as immunotherapy have long remained financially out of reach. The emergence of biosimilar immunotherapy drugs is now beginning to change that landscape, significantly lowering treatment …